Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

28 in total

1. Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study.

Authors: Olivier Mir; Jean-Philippe Durand; Pascaline Boudou-Rouquette; Julie Giroux; Romain Coriat; Anatole Cessot; Stanislas Ropert; François Goldwasser; Raphaël Gaillard
Journal: Support Care Cancer Date: 2012-05-30 Impact factor: 3.603

Review 2. A review of clinical practice guidelines for lung cancer.

Authors: Jutta J von Dincklage; David Ball; Gerard A Silvestri
Journal: J Thorac Dis Date: 2013-10 Impact factor: 2.895

3. KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.

Authors: Lihua Tong; Yingshan Luo; Ting Wei; Linlang Guo; Haihong Wang; Weiliang Zhu; Jian Zhang
Journal: Mol Cell Biochem Date: 2016-09-19 Impact factor: 3.396

4. Benefit from ifosfamide treatment in small-cell lung cancer: A meta-analysis.

Authors: Huizhen Yang; Yun Ma; Zhida Liu; Zheng Wang; Baohui Han; Lijun Ma
Journal: Mol Clin Oncol Date: 2014-11-25

5. Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.

Authors: L Knez; M Košnik; T Ovčariček; A Sadikov; E Sodja; I Kern; T Cufer
Journal: J Cancer Res Clin Oncol Date: 2012-04-29 Impact factor: 4.553

Review 6. Immunotherapy prospects in the treatment of lung cancer and mesothelioma.

Authors: Joachim G Aerts; Lysanne A Lievense; Henk C Hoogsteden; Joost P Hegmans
Journal: Transl Lung Cancer Res Date: 2014-02

Review 7. Management of small cell lung cancer: recent developments for optimal care.

Authors: Raffaele Califano; Aidalena Z Abidin; Rahul Peck; Corinne Faivre-Finn; Paul Lorigan
Journal: Drugs Date: 2012-03-05 Impact factor: 9.546

Review 8. Progress in the management of limited-stage small cell lung cancer.

Authors: Arya Amini; Lauren A Byers; James W Welsh; Ritsuko U Komaki
Journal: Cancer Date: 2013-12-10 Impact factor: 6.860

9. The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.

Authors: Marina Petrović; Zoran Bukumirić; Vladimir Zdravković; Slobodanka Mitrović; Henry Dushan Atkinson; Vladimir Jurišić
Journal: Med Oncol Date: 2013-12-30 Impact factor: 3.064

10. Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.

Authors: Jonathan M Lehman; Megan D Hoeksema; Jeremy Staub; Jun Qian; Bradford Harris; J Clay Callison; Jennifer Miao; Chanjuan Shi; Rosana Eisenberg; Heidi Chen; Sheau-Chiann Chen; Pierre P Massion
Journal: Int J Cancer Date: 2018-10-09 Impact factor: 7.396